Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Hum. Neurosci.

Sec. Brain Imaging and Stimulation

This article is part of the Research TopicDeep Brain Stimulation think tank: Updates in neurotechnology and neuromodulation, Volume VIView all 5 articles

Proceedings of the 13th Annual Deep Brain Stimulation Think Tank: The Evolving Landscape

Provisionally accepted
  • 1University of Florida Norman Fixel Institute for Neurological Diseases, Gainesville, United States
  • 2University of Florida J Crayton Pruitt Family Department of Biomedical Engineering, Gainesville, United States
  • 3Department of Clinical Neurosciences, University Hospital Lausanne (CHUV), Lausanne, Switzerland
  • 4Defitech Center for Interventional Neurotherapies (NeuroRestore), University Hospital Lausanne and EPFL, Lausanne, Switzerland
  • 5University of Minnesota Twin Cities Center for Magnetic Resonance Research, Minneapolis, United States
  • 6Department of Neurological Surgery, University of California San Francisco, San Francisco, United States
  • 7Charite - Universitatsmedizin Berlin Klinik fur Neurologie mit Experimenteller Neurologie, Berlin, Germany
  • 8Charite - Universitatsmedizin Berlin Einstein Zentrum fur Neurowissenschaften Berlin, Berlin, Germany
  • 9Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
  • 10Fudan University Institute of Science and Technology for Brain-inspired Intelligence, Shanghai, China
  • 11Medipace Inc, Pasadena, United States
  • 12Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
  • 13Departments of Neurology, Psychiatry, and Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States
  • 14Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, United States
  • 15Department of Neurosurgery, University of California, Los Angeles, United States
  • 16Boston Scientific Neuromodulation, Valencia, United States
  • 17Abbott Neuromodulation, Plano, United States
  • 18NeuroPace Inc, Mountain View, United States
  • 19Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc, Minneapolis, United States
  • 20Harvard Medical School Center for Bioethics, Boston, United States
  • 21Department of Psychiatry and Behavioral Sciences, Massachusetts General Hospital, Boston, United States
  • 22The Windreich Department of Artificial Intelligence and Human Health, Mount Sinai Medical Center, New York, United States
  • 23Cleveland Clinic Center for Neurological Restoration, Cleveland, United States
  • 24Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, United States
  • 25Icahn School of Medicine at Mount Sinai Department of Psychiatry, New York, United States
  • 26Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, United States
  • 27Icahn School of Medicine at Mount Sinai Department of Neurosurgery, New York, United States
  • 28University of Pennsylvania Department of Neurosurgery, Philadelphia, United States
  • 29University of Pennsylvania Department of Psychiatry, Philadelphia, United States
  • 30Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
  • 31Department of Engineering Science, University of Oxford, Oxford, United Kingdom
  • 32Cadence Neuroscience, Redmond, United States
  • 33Stanford University Stanford University Department of Neurology & Neurological Sciences, Stanford, United States
  • 34Stanford University Department of Neurosurgery, Stanford, United States
  • 35Parkinson's Foundation Inc, New York, United States
  • 36Department of Neurology, Baylor College of Medicine, Houston, United States
  • 37Department of Neurology, University of California San Francisco, San Francisco, United States
  • 38Universitat zu Lubeck Institut fur Neurogenetik, Lübeck, Germany
  • 39Universitatsklinikum Schleswig-Holstein Campus Lubeck Klinik fur Neurologie, Lübeck, Germany
  • 40University of Florida Lillian S. Wells Department of Neurosurgery, Gainesville, United States
  • 41University of Florida Department of Neurology, Gainesville, United States

The final, formatted version of the article will be published soon.

The Deep Brain Stimulation (DBS) Think Tank XIII was held September 2-4th, 2025, in Gainesville, Florida, at the Norman Fixel Institute for Neurological Diseases at the University of Florida. The theme was "The Evolving Landscape of DBS: New Indications, New Goals." This theme was a continuation of the DBS Think Tank XI and XII, which were focused on emerging technology and pushing the horizon of indications. Since its founding in 2012, the DBS Think Tank has provided a global forum for leading clinicians, engineers, and researchers in both in industry and academia to present, discuss, and debate the current state of DBS technologies as well as to consider important logistics and ethical challenges. Over the course of three days, members of each panel presented and facilitated discussions on the cutting edge of DBS research. The keynote speaker was Dr. Kamil Uğurbil of the University of Minnesota, who led the first group of researchers to demonstrate the feasibility of imaging the human brain using fMRI technology and who was a pioneer in the development of high-field human MRI scanning. Nobel laureate Dr. Stanley Prusiner, from the University of California, San Francisco, used the story of the discovery of prions to demonstrate the power of pursuing a finding even when the idea conflicted with the prevailing state of the field. The think tank was divided into sections, including: Next Generation Neuromodulation for Gait, Brain Networks and Neuromodulation, Neuroscience & Society, Interventional Psychiatry & Behavior, Devices for Closing the Loop, Physiology & Closing the Loop, and A Roadmap for Genetics & Neuromodulation.

Keywords: Closed Loop Stimulation, Deep Brain Stimulation, Neuroethics, Neurogenetics, Neuromodulation

Received: 18 Dec 2025; Accepted: 09 Feb 2026.

Copyright: © 2026 Fleeting, M. Moraud, Uğurbil, Wang, Neumann, Kühn, Voon, Pikov, Welter, Fox, Rolston, Malekmohammadi, Pathak, Himes, Greene, Becker, Lázaro-Muño, Charney, Merner, Figee, Scangos, Denison, Leyde, Gunduz, Bronte-Stewart, Beck, Arroyave, San Luciano, Brüggemann, Foote, Okun and Wong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Chance R. Fleeting

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.